Benefits of Pfizer Child Shot Likely Outweigh Risks, FDA Says

The staff of the Food and Drug Administration said the benefits of Pfizer Inc. and BioNTech SE's Covid-19 vaccine for young children likely outweigh its risks, ahead of a meeting next week where experts will weigh whether the shot should be cleared for ...

from Google Alert - Business https://ift.tt/3jul6pU
The staff of the Food and Drug Administration said the benefits of Pfizer Inc. and BioNTech SE's Covid-19 vaccine for young children likely outweigh its risks, ahead of a meeting next week where experts will weigh whether the shot should be cleared for ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize